Safety and Immunogenicity Study of a 13-valent Pneumococcal Polysaccharide Conjugate Vaccine
Clinical trial NCT05092386 · COMPLETED
Trial details
- NCT number
- NCT05092386
- Sponsor
- Sinovac Life Sciences Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-03
- Primary completion
- 2024-05-26
- Enrollment
- 310
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.